The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Synthesis and applications of sequence-defined oligo(amidoamines) to mimic and modulate bioadhesion processes
Date
April 8, 2021
Adhesion phenomena are crucial in numerous biological interactions and are often controlled by biomacromolecules such as proteins or polysaccharides. In order to better understand but also to potentially control or modulate adhesion processes, we can apply biomimetic macromolecules. Previously, we have introduced the so-called solid phase polymer synthesis to allow for the straightforward preparation of different sequence-defined peptide- and glycomimetic macromolecules. Through the stepwise assembly of tailor-made building blocks, we obtain oligo(amidoamine) scaffolds that can be used for the site-specific introduction of various functional groups, including bioligands and reactive moieties such as catechol units. We can control the types, number and positions of these different functional moieties as well as the architecture of the resulting macromolecule. This talk will highlight two recent examples on how we used solid phase polymer synthesis to create model systems and modulators of bioadhesion. In the first example, catechol groups – an important component of many natural glues – together with amine and amide groups are combined in a sequence-defined fashion using our scaffolds and investigated for their adhesion towards glass surfaces. Surprisingly, it is not only the combination of catechols and amines/amides but also their sequence that leads to a synergistic effect and highly improved adhesion properties. In the second example, we combine the catechol unit with carbohydrate ligands to create efficient inhibitors of bacterial adhesion. Notably, we observed carbohydrate ligands can bind to the adhesion sites of the bacteria but only upon addition of the catechol units is the binding site blocked permanently.
Biological processes on the cellular scale are mediated to a great extent by interactions between car-bohydrate ligands and their receptors, e.g. cell-cell communication, pathogen invasion, or cell development…
One of the major difficulties in the treatment of cancer is the formation of metastases. Since metastases are often caused by circulating tumor cells (CTCs), their early detection is of great importance…
One challenge in studying carbohydrate-protein interactions is the low binding affinity of individual carbohydrates. Biological systems overcome this through the multivalent presentation of carbohydrates as glycoconjugates on proteins, lipids or cell surfaces…
Adhesion to biological interfaces is dominated by carbohydrate interactions, where multivalency has a crucial role in determining binding specificity. Carbohydrate ligand-protein complexes control many physiological processes in healthy or diseased states…